Neena M Patil is EVP & Chief Legal Officer of Jazz Pharmaceuticals plc. Currently has a direct ownership of 33,048 shares of JAZZ, which is worth approximately $3.94 Million. The most recent transaction as insider was on Nov 08, 2024, when has been sold 3,700 shares (Ordinary Shares) at a price of $123.41 per share, resulting in proceeds of $456,617. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 33K
9.78% 3M change
13.23% 12M change
Total Value Held $3.94 Million

Neena M Patil Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 08 2024
SELL
Open market or private sale
$456,617 $123.41 p/Share
3,700 Reduced 10.07%
33,048 Ordinary Shares
May 03 2024
SELL
Open market or private sale
$548,250 $109.65 p/Share
5,000 Reduced 12.01%
36,629 Ordinary Shares
Mar 05 2024
SELL
Payment of exercise price or tax liability
$403,362 $117.53 p/Share
3,432 Reduced 7.62%
41,629 Ordinary Shares
Mar 01 2024
BUY
Grant, award, or other acquisition
-
12,348 Added 21.51%
45,061 Ordinary Shares
Jan 17 2024
SELL
Payment of exercise price or tax liability
$197,279 $119.13 p/Share
1,656 Reduced 4.82%
32,713 Ordinary Shares
Jan 17 2024
BUY
Grant, award, or other acquisition
-
5,087 Added 12.89%
34,369 Ordinary Shares
Sep 01 2023
SELL
Open market or private sale
$216,375 $144.25 p/Share
1,500 Reduced 4.89%
29,186 Ordinary Shares
Aug 15 2023
SELL
Open market or private sale
$104,692 $139.59 p/Share
750 Reduced 2.39%
30,686 Ordinary Shares
Aug 07 2023
SELL
Sale (or disposition) back to the issuer
$182,798 $131.51 p/Share
1,390 Reduced 4.23%
31,436 Ordinary Shares
Jun 01 2023
SELL
Open market or private sale
$204,784 $127.99 p/Share
1,600 Reduced 4.65%
32,826 Ordinary Shares
Mar 05 2023
SELL
Payment of exercise price or tax liability
$274,565 $142.78 p/Share
1,923 Reduced 5.3%
34,339 Ordinary Shares
Mar 03 2023
BUY
Grant, award, or other acquisition
-
9,419 Added 20.62%
36,262 Ordinary Shares
Nov 16 2022
SELL
Open market or private sale
$499,613 $142.34 p/Share
3,510 Reduced 11.59%
26,769 Ordinary Shares
Aug 05 2022
SELL
Payment of exercise price or tax liability
$203,064 $153.72 p/Share
1,321 Reduced 4.18%
30,279 Ordinary Shares
Jun 06 2022
SELL
Open market or private sale
$152,150 $152.15 p/Share
1,000 Reduced 3.07%
31,600 Ordinary Shares
May 10 2022
SELL
Bona fide gift
-
161 Reduced 0.49%
32,516 Ordinary Shares
May 06 2022
SELL
Open market or private sale
$45,560 $153.92 p/Share
296 Reduced 0.9%
32,677 Ordinary Shares
Mar 05 2022
SELL
Payment of exercise price or tax liability
$189,063 $153.96 p/Share
1,228 Reduced 3.59%
32,973 Ordinary Shares
Mar 03 2022
BUY
Grant, award, or other acquisition
-
8,886 Added 20.62%
34,201 Ordinary Shares
Aug 05 2021
SELL
Payment of exercise price or tax liability
$147,451 $148.49 p/Share
993 Reduced 3.79%
25,233 Ordinary Shares
Mar 05 2021
SELL
Payment of exercise price or tax liability
$113,842 $164.75 p/Share
691 Reduced 2.57%
26,147 Ordinary Shares
Feb 25 2021
BUY
Grant, award, or other acquisition
-
7,270 Added 21.31%
26,838 Ordinary Shares

Also insider at

TFX
TELEFLEX INC Healthcare
NMP

Neena M Patil

EVP & Chief Legal Officer
Dublin 4, L2

Track Institutional and Insider Activities on JAZZ

Follow Jazz Pharmaceuticals plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JAZZ shares.

Notify only if

Insider Trading

Get notified when an Jazz Pharmaceuticals PLC insider buys or sells JAZZ shares.

Notify only if

News

Receive news related to Jazz Pharmaceuticals plc

Track Activities on JAZZ